Insider Transactions in Q3 2022 at Terns Pharmaceuticals, Inc. (TERN)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 07
2022
|
Vivo Opportunity, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
600,000
+14.35%
|
$1,800,000
$3.6 P/Share
|
|
Sep 07
2022
|
Lu Hongbo Director |
BUY
Open market or private purchase
|
Indirect |
600,000
+14.35%
|
$1,800,000
$3.6 P/Share
|
|
Aug 16
2022
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
3,690,000
+34.35%
|
$7,380,000
$2.42 P/Share
|
|
Aug 16
2022
|
Carl L Gordon Director |
BUY
Open market or private purchase
|
Indirect |
3,690,000
+34.35%
|
$7,380,000
$2.42 P/Share
|
|
Aug 16
2022
|
Vivo Opportunity, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+33.47%
|
$3,000,000
$2.42 P/Share
|
|
Aug 16
2022
|
Lu Hongbo Director |
BUY
Open market or private purchase
|
Indirect |
1,500,000
+33.47%
|
$3,000,000
$2.42 P/Share
|
|
Aug 15
2022
|
Vivo Opportunity, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,218
+0.08%
|
$2,436
$2.99 P/Share
|
|
Aug 15
2022
|
Lu Hongbo Director |
BUY
Open market or private purchase
|
Indirect |
1,218
+0.08%
|
$2,436
$2.99 P/Share
|
|
Aug 12
2022
|
Vivo Opportunity, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,123,021
+43.14%
|
$2,246,042
$2.98 P/Share
|
|
Aug 12
2022
|
Lu Hongbo Director |
BUY
Open market or private purchase
|
Indirect |
1,123,021
+43.14%
|
$2,246,042
$2.98 P/Share
|